Highly diluted medication reduces parasitemia and improves experimental infection evolution by Trypanosoma cruzi

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Aleixo, Denise Lessa ^a   Ferraz, Fabiana Nabarro ^a   Ferreira, Érika Cristina ^a   De Lana, Marta ^b   Gomes, Mônica Lúcia ^a   De Abreu Filho, Benício Alves ^a   De Araújo, Silvana Marques ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

Biotherapy; Clinical evaluation; Mice infection; Parasitological evaluation; Prepatent period

Indexed keywords

ANIMALIA; MUS; TRYPANOSOMA CRUZI;

ANTIPARASITIC AGENT; BIOLOGICAL PRODUCT;

ANIMAL; ARTICLE; BIOLOGICAL THERAPY; BLOOD; CHAGAS DISEASE; DISEASE MODEL; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HOMEOPATHY; MALE; MOUSE; PARASITEMIA; PARASITOLOGY; PATHOPHYSIOLOGY; TIME; TRYPANOSOMA CRUZI;

ANIMALS; ANTIPARASITIC AGENTS; BIOLOGICAL AGENTS; BIOLOGICAL THERAPY; CHAGAS DISEASE; DISEASE MODELS, ANIMAL; HOMEOPATHY; MALE; MICE; PARASITEMIA; TIME FACTORS; TRYPANOSOMA CRUZI;

EID: 84866242978     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-352     Document Type: Article

References (33)

1. Lyrio C, Nosádios Bioterápicos: Repertário C. Lyrio, Rio de Janeiro 2002 22912353
2. Teorias Interpretativas sobre ultradiluiçes: Ilustraçes Experimentais. Bonamin LV, Cultura Homeopática 2006 16 6 17
3. Immunology and Homeopathy. 5. The Rationale of the Simile Bellavite P, Ortolani R, Pontarollo F, Pitari G, Conforti A, Evidence-Based Complementary and Alternative Medicine 2007 4 2 149 163 10.1093/ecam/nel117 17549232
4. Biotherapic of Trypanosoma cruzi 17x controlled histopathological alterations in mice infected by this protozoon. Sandri PF, Falkowski GJS, Nascimento Júnior AD, Spack M, Moreira NM, Toledo MJO, Abreu Filho B, Gabriel M, Araújo SM, International Journal of High Dilution Research 2011 10 36 119 12
5. Homeopathy and menopause. Thompson EA, J Br Menopause Soc 2002 8 4 151 154 12804324
6. Effects of homeopathic preparations on the liver in rats with acute and chronic toxic hepatitis. Vetoshkina TV, Fomina TI, Bull Exp Biol Med 2003 135 1 85 87 10.1023/A:1023414400387 12949661 (Pubitemid 36805714)
7. Effects of ultrahigh dilutions of 3,5-dichlorophenol on the luminescence of the bacterium Vibrio fischeri. Brack A, Strube J, Stoltz P, Decker H, Biochemical, Biophysical Acta 2003 1621 3 253 260 10.1016/S0304-4165(03)00076-X (Pubitemid 36638577)
8. Brasília DF, Farmacopéia Homeopática Brasileira Ed. Agência Nacional de Vigilncia Sanitária (ANVISA), Brasília DF 3 2011
9. Almeida LR, Efeitos de medicamentos Homeopáticos e Bioterápicos em Camundongos experimentalmente infectados por Trypanosoma evansi (STEEL, 1885) BALBIANI, 1988 e Trypanosoma cruzi CHAGAS, 1909 Tese Doutorado em Ciências Veterinárias - Instituto de Veterinária/ Universidade Federal Rural do Rio de Janeiro, Seropédica 2007 68
10. Research on Ultra-dilutions and the Theory of Corporeal Signifiers: The Follow Up. Bonamin LV, Lagache A, Bastide M, Signals and Images: Contributions and contradictions about high dilution research Ed. Springer, São Paulo: Bonamin LV 2008
11. Epidemiology, control and surveillance of Chagas disease-100 years after its discovery. Coura JR, Dias JC, Memárias do Instituto Oswaldo Cruz 2009 104 Suppl. I 31 40 22903442
12. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Silva LHP, Nussenzweig V, Folia Clínica Biologia São Paulo 1953 20 191 201 21734274
13. Life cycle of Trypanosoma cruzi (y strain) in mice. Pinto PLS, Takami R, Nunes EV, Guilherme CS, Oliveira JOC, Gama-Rodrigues J, Okumura M, Revista do Hospital das Clínicas 1999 54 141 146 22086531
14. A critical review on Chagas Disease Chemotherapy. Coura JR, Castro SL, Memárias do Instituto Oswaldo Cruz 2002 97 1 3 24 10.1590/S0074- 02762002000100001 22903442 (Pubitemid 135746197)
15. Endomyocardial biopsy in Chagas' heart disease: pathogenetic contributions. Higuchi MD, Sao Paulo Med J 1995 113 821 825 10.1590/S1516- 31801995000200013 8650482
16. Patogenia da doença de chagas. Tafuri WL, Rev Inst Med Trop São Paulo 1987 29 4 194 199 10.1590/S0036-46651987000400002
17. Veterinary Aspects and Experimental Studies. Desquesnes M, Lana M, American Trypanosomiasis Chagas Disease: one hundread year of research Elsevier Inc., London, Telleria J, Tibayrenc M, 2010
18. Sandri PF, Influência da idade sobre os efeitos do bioterápico 17 dH na infecção de camundongos pelo Trypanosoma cruzi. Dissertação (Mestrado em Biociências Aplicada a Farmácia) Universidade Estadual de Maringá, São Paulo, SP 2010 79 22712164
19. Possíveis contribuiçes do modelo homeopático humanização da formação médica. Teixeira MZ, Revista Brasileira de Educação Médica 2009 33 454 463
20. Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. Dodoo D, Omer FM, Todd J, Akanmori BD, Koram KA, Riley EM, Journal of Infectious Disease 2002 185 7 971 979 10.1086/339408 (Pubitemid 34274441)
21. Pathogenesis of malaria and clinically similar conditions. Clark IA, Alleva LM, Mills AC, Cowden WB, Clin Microbiol Rev 2004 17 3 509 539 10.1128/CMR.17.3.509-539.2004 15258091 (Pubitemid 38970680)
22. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen. Jones TR, Narum DL, Gozalo AS, Aguiar J, Fuhrmann SR, Liang H, Haynes JD, Moch JK, Lucas C, Luu T, Journal of Infectious Disease. 2001 183 2 303 312 10.1086/317933 (Pubitemid 32066033)
23. Blood and bone marrow changes in malaria. Wickramasinghe SN, Abdalla SH, Baillieres Best Practice and Research Clinical Haematology 2000 13 2 277 299 10.1053/beha.1999.0072
24. Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole. Claudia TM, Mônica LG, Aline VM, Silvana MA, Maria TB, Olindo AM, Marta L, Max JOT, Exp Parasitol 2008 120 1 45 49 10.1016/j.exppara. 2008.04.018 18533149
25. Telleria J, Tibayrenc M, American Trypanosomiasis Chagas Disease: one hundread year of research Elsevier Inc, London 2010
26. Modelos experimentais para o estudo in vivo da doença de Chagas: Camundongo. Araújo-Jorge TC, Doença de Chagas: Manual de experimentação animal. Fiocruz 2000 21560320
27. Different forms of administration of biotherapy 7dH in mice experimentally infected by Trypanosoma cruzi produce different effects. Ferraz FN, Simoni GK, Nascimento AD, Melo CS, Aleixo DL, Gomes ML, Spaki M, Araújo SM, Homeopathy 2011 100 237 243 10.1016/j.homp.2011.05.006 21962198
28. Estudos sobre o comportamento em camundongos de uma amostra altamente virulenta de Trypanosoma cruzi (Amostra Y), apás passagem em triatomíneos, ratos e culturas. Carvalheiro JR, Collares EF, Rev Bras Biol 1965 25 169 75 5853395
29. Parmetros hematolágicos em camundongos infectados pelo Trypanosoma cruzi e tratados com bioterápicos. Billotti C, Ferraz FN, Spack M, Nascimento Júnior AD, Panza S, Alvares AA, Gomes ML, Toledo MJ, Martinichen JC, Araújo SM, Brazilian Homeopathic Journal 2009 11 9 10
30. Biotherapic of Trypanosoma cruzi 17d increases apoptosis in experimentally infected mice. Sandri PF, Falkowski GJS, Hernandes L, Dalalio MO, Aleixo DL, Gomes ML, Anélio DN, Moliterno RA, Araujo SM, Proceedings of the XXV GIRI Symposium and VIII CBFH on International Journal of High Dilution Research 2011 2011 119 124
31. BRASIL Ministério da Saúde, RESOLUO DA DIRETORIA COLEGIADA-RDC N° 67 Diário Oficial da União, Brasília (DF), Diário Oficial da União, Brasília (DF) 2007 8 de outubro de 2007 22480553
32. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Brener Z, Rev Inst Med Trop São Paulo 1962 4 189 196
33. Acute experimental Trypanosoma cruzi infection: establishing a murine model that utilizes non-invasive measurements of disease parameters. Silva DR, Castro SL, Alves MCS, Batista WS, Oliveira GM, Memárias do Instituto Oswaldo Cruz 2012 107 2 211 216 22903442